These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 14036589)

  • 1. The action of "Penbritin" on Brucella micro-organisms.
    AGIUS E; MIFSUD J
    Arch Inst Pasteur Tunis; 1962 Mar; 39():97-101. PubMed ID: 14036589
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of glycine and a lysozymelike agent from rabbit monocytes in destruction of Brucella.
    RALSTON DJ; ELBERG SS
    Proc Soc Exp Biol Med; 1960 Jul; 104():464-7. PubMed ID: 14435990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivity of strains of Brucella isolated from humans and animals to various antibiotics].
    GUERRA M; SUGHI R
    Nuovi Ann Ig Microbiol; 1960; 11():255-7. PubMed ID: 13709471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Further studies on the metabolism and variability of Brucella brucei strains highly resistant to streptomycin].
    PARNAS J; KOTLINSKA E
    Ann Univ Mariae Curie Sklodowska Med; 1960; 15():185-94. PubMed ID: 14038191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of antibiotic-resistant types of Brucella].
    URALEVA VS
    Antibiotiki; 1961 Sep; 6():46-51. PubMed ID: 13923878
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of penicillin on genetic changes and temporary modifications in populations of brucellae.
    BRAUN W; KRAFT M; MEAD DD; GOODLOW RJ
    J Bacteriol; 1952 Jul; 64(1):41-7. PubMed ID: 14946097
    [No Abstract]   [Full Text] [Related]  

  • 7. A new variant of Brucella melitensis.
    Lucero NE; Ayala SM; Escobar GI; Grayon M; Jacques I
    Clin Microbiol Infect; 2006 Jun; 12(6):593-6. PubMed ID: 16700714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time PCR for identification of Brucella spp.: a comparative study of IS711, bcsp31 and per target genes.
    Bounaadja L; Albert D; Chénais B; Hénault S; Zygmunt MS; Poliak S; Garin-Bastuji B
    Vet Microbiol; 2009 May; 137(1-2):156-64. PubMed ID: 19200666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cultural similarities of the Brucellae and unidentified Brucella-like organisms.
    MARTIN P; PRITCHARD MT; MIELCAREK JE; ROWLAND JL
    J Am Osteopath Assoc; 1954 Jul; 53(11):613-6. PubMed ID: 13174414
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immune responses differentiate infections with Brucella suis from Yersinia enterocolitica serotype O:9 in pigs.
    Riber U; Jungersen G
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):13-25. PubMed ID: 17270281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB.
    Dozot M; Boigegrain RA; Delrue RM; Hallez R; Ouahrani-Bettache S; Danese I; Letesson JJ; De Bolle X; Köhler S
    Cell Microbiol; 2006 Nov; 8(11):1791-802. PubMed ID: 16803581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM; Estevan M; Marín CM; Jesús De Miguel M; Jesús Grilló M; Barberán M; Irache JM; Blasco JM; Gamazo C
    Vaccine; 2006 Mar; 24(11):1897-905. PubMed ID: 16337315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The penicillins].
    DAUCHY F
    Concours Med; 1960 Dec; 82():5921-8. PubMed ID: 13719899
    [No Abstract]   [Full Text] [Related]  

  • 14. Part III. Penicillins.
    Gibbs WJ; Cooper TW; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2006 Nov; 99(11):551-6. PubMed ID: 17191689
    [No Abstract]   [Full Text] [Related]  

  • 15. A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.
    Delpino MV; Marchesini MI; Estein SM; Comerci DJ; Cassataro J; Fossati CA; Baldi PC
    Infect Immun; 2007 Jan; 75(1):299-305. PubMed ID: 17088355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis.
    Billard E; Cazevieille C; Dornand J; Gross A
    Infect Immun; 2005 Dec; 73(12):8418-24. PubMed ID: 16299342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies on the mechanism of therapeutic action of brucellin PS].
    PARNAS J; PREJBISZ B; GIETKA M
    Ann Univ Mariae Curie Sklodowska Med; 1953; 8():27-36. PubMed ID: 14350425
    [No Abstract]   [Full Text] [Related]  

  • 18. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
    Prior S; Gander B; Lecároz C; Irache JM; Gamazo C
    J Antimicrob Chemother; 2004 Jun; 53(6):981-8. PubMed ID: 15102748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella lipopolysaccharide acts as a virulence factor.
    Lapaque N; Moriyon I; Moreno E; Gorvel JP
    Curr Opin Microbiol; 2005 Feb; 8(1):60-6. PubMed ID: 15694858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antimicrobial susceptibility of Brucella species.
    Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
    Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.